TEVA — TEVA PHARMACEUTICAL INDS LTD

Ownership history in VIKING GLOBAL INVESTORS LP  ·  11 quarters on record

This page tracks every 13F SEC filing in which VIKING GLOBAL INVESTORS LP reported a position in TEVA PHARMACEUTICAL INDS LTD (TEVA). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
7.77% (2016 Q1)
Avg. % of fund
2.54%
First filed
2015 Q1
Last filed
2025 Q3
Quarters held
11
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 REDUCED 2,532,119 -9,149,214 -78.3% 0.13% $51.1M $20.20
2025 Q2 ADDED 11,681,333 +1,555,855 +15.4% 0.57% $195.8M $16.76
2025 Q1 ADDED 10,125,478 +3,621,993 +55.7% 0.49% $155.6M $15.37
2024 Q4 REDUCED 6,503,485 -1,064,048 -14.1% 0.46% $143.3M $22.04
7 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    TEVA price (monthly, adj. close)

Other funds also holding TEVA

As of 2025 Q4 — sorted by position size

GordonMD Global Investments LP 17.22% Lingotto Investment Management LLP 3Y 7Y 15.46% Phoenix Financial Ltd. 3Y 13.9% GLENVIEW CAPITAL MANAGEMENT, LLC 3Y 7Y 10.62% Rubric Capital Management LP 3Y 7Y 7.97% BRIDGER MANAGEMENT, LLC 3Y 7Y 7.38% Parsifal Capital Management, LP 3Y 7.22% SPHERA FUNDS MANAGEMENT LTD. 3Y 7Y 6.78% Factorial Partners, LLC 3Y 7Y 5.98% Tri Locum Partners LP 3Y 5.82%
← Back to VIKING GLOBAL INVESTORS LP Holdings